These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 17961100)

  • 21. Impact of an adherence clinic on behavioral outcomes and virologic response in treatment of HIV infection: a prospective, randomized, controlled pilot study.
    Rathbun RC; Farmer KC; Stephens JR; Lockhart SM
    Clin Ther; 2005 Feb; 27(2):199-209. PubMed ID: 15811483
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The role of anger in adherence to highly active antiretroviral treatment in patients infected with HIV.
    Leombruni P; Fassino S; Lavagnino L; Orofino G; Morosini P; Picardi A
    Psychother Psychosom; 2009; 78(4):254-7. PubMed ID: 19468260
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Relationship between adherence level, type of the antiretroviral regimen, and plasma HIV type 1 RNA viral load: a prospective cohort study.
    Martin M; Del Cacho E; Codina C; Tuset M; De Lazzari E; Mallolas J; Miró JM; Gatell JM; Ribas J
    AIDS Res Hum Retroviruses; 2008 Oct; 24(10):1263-8. PubMed ID: 18834323
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Self-reported sexual dysfunction is frequent among HIV-infected persons and is associated with suboptimal adherence to antiretrovirals.
    Trotta MP; Ammassari A; Murri R; Marconi P; Zaccarelli M; Cozzi-Lepri A; Acinapura R; Abrescia N; De Longis P; Tozzi V; Scalzini A; Vullo V; Boumis E; Nasta P; Monforte Ad; Antinori A;
    AIDS Patient Care STDS; 2008 Apr; 22(4):291-9. PubMed ID: 18422461
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Adherence to directly observed antiretroviral therapy among human immunodeficiency virus-infected prison inmates.
    Wohl DA; Stephenson BL; Golin CE; Kiziah CN; Rosen D; Ngo B; Liu H; Kaplan AH
    Clin Infect Dis; 2003 Jun; 36(12):1572-6. PubMed ID: 12802758
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Piloting a peer-driven intervention model to increase access and adherence to antiretroviral therapy and HIV care among street-entrenched HIV-positive women in Vancouver.
    Deering KN; Shannon K; Sinclair H; Parsad D; Gilbert E; Tyndall MW
    AIDS Patient Care STDS; 2009 Aug; 23(8):603-9. PubMed ID: 19591602
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Time to viral load suppression in antiretroviral-naive and -experienced HIV-infected pregnant women on highly active antiretroviral therapy: implications for pregnant women presenting late in gestation.
    Aziz N; Sokoloff A; Kornak J; Leva NV; Mendiola ML; Levison J; Feakins C; Shannon M; Cohan D
    BJOG; 2013 Nov; 120(12):1534-47. PubMed ID: 23924192
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Self-reported symptoms after initiation of a protease inhibitor in HIV-infected patients and their impact on adherence to HAART.
    Duran S; Spire B; Raffi F; Walter V; Bouhour D; Journot V; Cailleton V; Leport C; Moatti JP;
    HIV Clin Trials; 2001; 2(1):38-45. PubMed ID: 11590513
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The impact of methadone or buprenorphine treatment and ongoing injection on highly active antiretroviral therapy (HAART) adherence: evidence from the MANIF2000 cohort study.
    Roux P; Carrieri MP; Villes V; Dellamonica P; Poizot-Martin I; Ravaux I; Spire B;
    Addiction; 2008 Nov; 103(11):1828-36. PubMed ID: 18778390
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Assessing the association between self-report items for HIV pill adherence and biological measures.
    Kagee A; Nel A
    AIDS Care; 2012; 24(11):1448-52. PubMed ID: 22670758
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Intention to adhere to HIV treatment: a patient-centred predictor of antiretroviral adherence.
    Nelsen A; Gupta S; Trautner BW; Petersen NJ; Garza A; Giordano TP; Naik AD; Rodriguez-Barradas MC
    HIV Med; 2013 Sep; 14(8):472-80. PubMed ID: 23551395
    [TBL] [Abstract][Full Text] [Related]  

  • 32. HAART with didanosine once versus twice daily: adherence and efficacy.
    Roca B; Lapuebla C; Vidal-Tegedor B
    Int J Infect Dis; 2005 Jul; 9(4):195-200. PubMed ID: 15964537
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Integration of motivational interviewing and cognitive behavioral therapy to improve HIV medication adherence and reduce substance use among HIV-positive men and women: results of a pilot project.
    Parsons JT; Rosof E; Punzalan JC; Di Maria L
    AIDS Patient Care STDS; 2005 Jan; 19(1):31-9. PubMed ID: 15665633
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Multiple self-report measures of antiretroviral adherence correlated in Sierra Leone, but did they agree?
    Kelly JD; Hubenthal EA; Lurton G; Empson SF; Barrie MB; Kargbo B; Wagner GJ; Giordano TP
    Int J STD AIDS; 2013 Dec; 24(12):931-7. PubMed ID: 23970613
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Predictors of adherence and virologic outcome in HIV-infected patients treated with abacavir- or indinavir-based triple combination HAART also containing lamivudine/zidovudine.
    Cahn P; Vibhagool A; Schechter M; Soto-Ramirez L; Carosi G; Smaill F; Jordan JC; Pharo CE; Thomas NE; Steel HM
    Curr Med Res Opin; 2004 Jul; 20(7):1115-23. PubMed ID: 15265256
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Enhancing adherence to HAART: a pilot program of modified directly observed therapy.
    Stenzel MS; McKenzie M; Mitty JA; Flanigan TP
    AIDS Read; 2001 Jun; 11(6):317-9, 324-8. PubMed ID: 11449925
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A time-to-prescription-refill measure of antiretroviral adherence predicted changes in viral load in HIV.
    Grossberg R; Zhang Y; Gross R
    J Clin Epidemiol; 2004 Oct; 57(10):1107-10. PubMed ID: 15528063
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Adherence to highly active antiretroviral therapy in the real world: experience of twelve English HIV units.
    Brook MG; Dale A; Tomlinson D; Waterworth C; Daniels D; Forster G
    AIDS Patient Care STDS; 2001 Sep; 15(9):491-4. PubMed ID: 11587635
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Outpatient pharmacy care and HIV viral load response among patients on HAART.
    Castillo E; Palepu A; Beardsell A; Akagi L; Yip B; Montaner JS; Hogg RS
    AIDS Care; 2004 May; 16(4):446-57. PubMed ID: 15203413
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A measurement model of medication adherence to highly active antiretroviral therapy and its relation to viral load in HIV-positive adults.
    Llabre MM; Weaver KE; Durán RE; Antoni MH; McPherson-Baker S; Schneiderman N
    AIDS Patient Care STDS; 2006 Oct; 20(10):701-11. PubMed ID: 17052140
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.